BofA analyst Chase Mulvehill downgraded Core Laboratories to Underperform from Neutral with a $21.50 price target. The firm cites valuation for the downgrade.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CLB:
